Biosynthesis of a VLP-type nanocarrier specific to cancer cells using the BEVS expression system for targeted drug delivery

Biosynthesis of a VLP-type nanocarrier specific to cancer cells using the BEVS expression system for targeted drug delivery

Abstract Objective Canine parvovirus (CPV) is a small virus without an envelope that consists of three viral proteins including VP1, VP2, and VP3. Exclusively, the VP2 can form a typically CPV-sized virus-like particle (CPV-VLP) that can be used as a biological nanocarrier for diagnostic and therape...

Full description

Bibliographic Details
Main Authors: Mohammad Sadegh Hashemzadeh, Nariman Gharari
Format: Article
Language:English
Published: SpringerOpen 2023-02-01
Series:Journal of Genetic Engineering and Biotechnology
Subjects:
CPV-VLP
BEVS system
VP2
Sf9 cell
Baculovirus
Online Access:https://doi.org/10.1186/s43141-023-00479-9

Similar Items

Similar Items